ANZSN MAIN PROGRAMME


MONDAY 27 AUGUST 2012

0820–0830 WELCOME
0830–0930 PLENARY SESSION 1
 Understanding dialysis-induced multiorgan injury and how we can prevent it
  A/Prof Christopher McIntyre
  University of Nottingham, UK
  Chair: A/Prof Vicki Levidiotis
  Proudly sponsored by Baxter and Shire
0930–1030 SEMINAR 1: CLINCIAL SCIENCE
 New approach of costimulation inhibition in allograft recipients
  Prof Jean-Paul Soulillou
  Nantes University Hospital, France
 Cardiac assessment for renal transplantation
  A/Prof Helen Pilmore
  Auckland District Health Board, Auckland, New Zealand
  Chair: Prof Paolo Ferrari
1030–1100 MORNING TEA AMONGST THE EXHIBITION
1100–1300 ANZSN YOUNG INVESTIGATOR AWARDS
  Chair: A/Prof Toby Coates
  001 MINERALOCORTICOID RECEPTOR ACTIVATION IN MACROPHAGES CONTRIBUTES TO RENAL INJURY IN PROGRESSIVE KIDNEY DISEASE
 Huang L, Nikolic-Paterson D, Han Y, Young M, Tesch G
  002 AN IMPACT OF NR1I2 GENOTYPE ON DOSE-ADJUSTED EXPOSURE TO TACROLIMUS AND BK VIRAEMIA IN ADULT KIDNEY TRANSPLANTATION
 Barraclough K, Isbel N, Lee K, Bergmann T, Johnson D, McWhinney B, Ungerer J, Campbell S, Leary D, Bialasiewicz S, Rockett R, Staatz C
  003 ABSENCE OF IL17 ATTENUATES REJECTION AND PROMOTES SURVIVAL IN A MURINE MODEL OF RENAL ALLOGRAFT TRANSPLANTATION
 Kwan T, Wu H, Alexander S, Chadban S
  004 CLINICAL OUTCOMES IN NSW PATIENTS ADMITTED WITH AMI AND CHRONIC KIDNEY DISEASE
 Kotwal S, Ranasinghe I, Foote C, Wang A, Cass A, Gallagher M
  005 MYELOPEROXIDASE PEPTIDE-SPECIFIC CD4+ T CELLS INDUCE INJURY IN MURINE ANTI-MYELOPEROXIDASE GLOMERULONEPHRITIS
 Chang J, Ooi J, Holdsworth S, Kitching A
  006 PREDICTORS OF ACUTE KIDNEY INJURY FOLLOWING ON PUMP CARDIAC SURGERY
 Grynberg K, Polkinghorne K, Barrett J, Summers S
  007 BLOCKADE OF SPLEEN TYROSINE KINASE (SYK) SUPPRESSES RENAL ISCHAEMIA-REPERFUSION INJURY BY REDUCING PLATELET AND NEUTROPHIL ACCUMMULATION
 Ryan J, Nikolic-Paterson D, Ma F, Blease K, Kanellis J
  008 TIMING OF RENAL REPLACEMENT THERAPY AND PATIENT OUTCOMES IN THE RANDOMIZED EVALUATION OF NORMAL VS. AUGMENTED LEVEL OF REPLACEMENT THERAPY TRIAL
 Jun M, Bellomo R, Cass A, Gallagher M, Lo S
1300–1400 LUNCH AMONGST THE EXHIBITION
1400–1530 ORAL MINI-POSTERS 1
  Haemodialysis: Vascular Access
  Co-Chairs: A/Prof Kevan Polkinghorne, Dr David Voss
  009 TACKLING THE TRANSFER FROM PD TO HD
 Lan P, Clayton P, Saunders J, Polkinghorne K, Snelling P
  010 PRE-EMPTIVE VASCULAR ACCESS FOR HAEMODIALYSIS
 Hossain M, Karpe K, Walters G, Talaulikar G
  011 A SURVEY OF CURRENT PROCEDURAL PRACTICES OF AUSTRALIAN AND NEW ZEALAND NEPHROLOGISTS
 Ritchie A, Saunders J, Baer R, May S
  012 A VASCULAR ACCESS COORDINATOR IMPROVES INCIDENT AND PREVALENT ARTERIO-VENOUS FISTULA RATES – AN INVESTMENT WORTHY OF A LIFELINE
 Jabbar Z, Maurice K, Treacy P, Gawler D
  013 HIGH INCIDENCE OF STAPHYLOCOCCUS AUREUS BACTERAEMIA IN INDIGENOUS HAEMODIALYSIS PATIENTS IS NOT A RESULT OF CATHETER RELATED INFECTIONS
 Tong S, Kobayashi N, Davis J, Jeremiah C, Perry G
  014 UPPER ARM ARTERIO-VENOUS FISTULAE USING AUTOLOGOUS SUPERFICIAL FEMORAL VEIN FOR HAEMODIALYSIS VASCULAR ACCESS: FIRST REPORT FROM THE ASIA-PACIFIC
 Jabbar Z, Maurice K, Treacy P, Gawler D
  015 INTERVENTIONAL NEPHROLOGIST MODEL OF DIALYSIS ACCESS
 Baer R, Killen J, Hakim H, Srivastava V, Wu R, Steffen C, Grainer F, Moffatt J, Mantha M
  016 ANTICOAGULANTS FOR PREVENTION OF INTRAVASCULAR CATHETERS MALFUNCTION IN PATIENTS UNDERGOING HEMODIALYSIS: SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED, CONTROLLED TRIALS
 Wang Y, Ivany J, Barzi F, Perkovic V, Gallagher M, Jardine M
  017 ELDERLY PATIENTS SHOULD HAVE PRE-EMPTIVE VASCULAR ACCESS CREATED FOR CHRONIC HAEMODIALYSIS
 Hossain M, Karpe K, Walters G
  018 A STUDY OF HAEMODIALYSIS CATHETER INFECTION RATES USING THE BIOPATCH
 Wong E, Mount P, Cook M, Ross-Smith M
  019 SUCCESS RATE OF THE FIRST DIALYSIS SESSION POST TUNNELLED DIALYSIS CATHETER(TDC) INSERTION
 Dahwa R, Martinez-Garcia J, Lee C, Ratanjee S
  020 REVIEW OF PERCUTANEOUS FISTULA ANGIOPLASTY IN MAINTAINING AV FISTULAE IN A RURAL HOSPITAL
 May S, Qassabian R
  021 INITIAL EXPERIENCE OF OPENING OCCLUDED FISTULA WITH PERCUTANEOUS TECHNIQUES IN A RURAL SETTING
 May S, Qassabian R
  022 A DIALYSIS-BASED INVESTIGATION OF THE ORIGINS OF INVASIVE STAPHYLOCOCCUS AUREAS BACTERAEMIA: STUDY AIMS AND METHODS
 Hughes J, Holloway L, Hall H, Perry G, Tong S, Holt D, Giffard P
  023 ASSESSMENT OF HEMODIALYSIS PATIENTS IN A GOVERNMENT TERTIARY RENAL CARE FACILITY OF BANGLADESH
 Iqbal M, Chowdhury A, Roy D, Nahar N, Ahmed S, Khan M, Ahmed S
  024 THE EFFECT OF HEMODIALYSIS TO INFLAMMATORY PROFILE MEASURED BY INTERLEUKIN-6, INTERLEUKIN-18, AND C-REACTIVE PROTEIN
 Jonny J, Supriyadi R, Gondodiputro R, Roesly R
1400–1530 ORAL MINI-POSTERS 2
  Haemodialysis: CKD-MBD/Anaemia/Adequacy/Other
  Co-Chairs: A/Prof Carmel Hawley, Dr Colin Hutchinson
  025 IMPLEMENTING RENAL ANAEMIA GUIDELINES USING A STANDARDISED TREATMENT ALGORITHM AT A UNIT LEVEL
 Kotwal S, Lan P, Jardine M, Mcleod A, Snelling P, Cass A, Gallagher M
  026 IMPLEMENTATION OF THE CARI IRON GUIDELINE INTO RURAL NEPHROLOGY PRACTICE
 Irving M, MacGinley R, Featherstonhaugh D, Walker R, Gallagher M, Cross N, Craig J
  027 LONG TERM EFFECTS OF NOCTURNAL HOME HAEMODIALYSIS ON LEFT VENTRICULAR MASS INDEX: AN OBSERVATIONAL STUDY
 Hutton H, Perkins A, Agar J, Somerville C
  028 HIGH SENSITIVITY TROPONIN AS A PREDICTIVE MARKER FOR CARDIAC EVENTS AND MORTALITY IN THE STABLE DIALYSIS POPULATION
 Cheikh Hassan H, Suranyi M, Aravindan A, Hall B, Howlin K, Jefferys A, Spicer T, Suryanarayanan G, Wong J, Cleland BMakris A
  029 DOES EARLY NEPHROLOGICAL CARE MATTER? A RETROSPECTIVE COMPARISON STUDY OF THE INITIATING DIALYSIS EARLY AND LATE (IDEAL) STUDY LATE STARTERS VERSUS AUSTRALIAN NEW ZEALAND DATA REGISTRY (ANZDATA) LATE STARTERS
 Wong M, Clayton P, Cooper B, Branley P, Collins J, Craig J, Fraenkel M, Harris A, Luxton G, Pilmore A, Tiller D, Johnson D, McDonald S, Harris D, Pollock C
  030 ELEVEN KEY AREAS OF RENAL NURSE RESPONSIBILITY – THE FOUNDATIONS OF QUALITY PATIENT DIALYSIS OUTCOMES
 Bunani A, Sedgewick J, Paguia D, John J, Lehbi A
  031 HAEMOGLOBIN VARIABILITY AS A PREDICTOR OF ALL-CAUSE MORTALITY IN HAEMODIALYSIS PATIENTS
 Abeyaratne A, Bannister K
  032 ASSESSMENT OF METABOLIC ACIDOSIS IN END STAGE RENAL DISEASE (ESRD) PATIENTS ON MAINTENANCE HEMODIASLYSIS BY ARTERIAL BLOOD GAS ANALYSIS AND SERUM ELECTROLYTE MEASUREMENTS
 Islam R, Roy D, Iqbal M, Chowdhury A, Karim R, Hossain M
  033 QUALITY OF LIFE OF ADULT CLIENTS WITH HEMODIALYSIS AND RENAL TRANSPLANTATION
 Sedhain A, Sapkota A
  034 REGIONAL CITRATE DIALYSIS RESULTS IN A SMALL NEGATIVE CALCIUM FLUX
 Singer R, Williams O, Talaulikar G
  035 ANTICOAGULATION OR NOT FOR HAEMODIALYSIS PATIENTS WITH ATRIAL FIBRILLATION: A DECISION ANALYSIS
 Wyld M, Clayton P, Morton R, Chadban S
  036 VRE COLONISATION IN ESRF: A RETROSPECTIVE CASE CONTROL STUDY OF ITS EFFECT ON LENGTH OF STAY AND MORTALITY
 Polkinghorne K, Garner S, Kotsanas D, Kerr P, Stuart R
  037 SURVIVAL OF PEOPLE WITH MYELOMA AND END STAGE KIDNEY DISEASE TREATED WITH DIALYSIS
 Webster A, Kelly P, Wong G
  038 PREDICTORS OF PHYSICAL PERFORMANCE IN PATIENTS ON MAINTENANCE HAEMODIALYSIS
 Wang Y, Sherrington C, Barzi F, Krishnan A, Gallagher M, Snelling P, Cass A, Jardine M
  039 SLEEP APNOEA IS COMMON AND SYMPTOMS ARE UNDER REPORTED IN HAEMODIALYSIS PATIENTS
 Singer R, Huang H, Talaulikar G, Walters G, Karpe K
  040 APPLICABILITY OF INTERNATIONAL RECOMMENDATIONS FOR DIETARY PROTEIN IN AN AUSTRALIAN HAEMODIALYSIS POPULATION
 Piccini S, Fairburn A, Gill E, O'Sullivan T
  041 DOES PRESCRIBED AND DELIVERED HAEMODIALYSIS TREATMENT TIME DIFFER?
 Noble E, Gray N
1400–1530 ORAL MINI-POSTERS 3
  CKD: Glomerulonephritis
  Co-Chairs: Prof Peter Kerr, Dr Chen Au Peh
  042 DETECTION OF PLA2R ANTIBODIES IN PATIENTS WITH MEMBRANOUS NEPHROPATHY USING A CELL-BASED IMMUNOFLUORESCENCE ASSAY
 McGettigan B, Dheda S, Blundell C, Webb-Smith E, Ferrari P
  043 ANCA-ASSOCIATED VASCULITIS IN AUCKLAND 1998–2008
 de Zoysa J, Kendrick-Jones J, Lam M, Yehia M
  044 ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE OCCURRING DURING PREGNANCY
 O'Shea S, Francis R, Sammartino C, Ratanjee S, Gray N
  045 MANAGEMENT OF IDIOPATHIC MEMBRANOUS NEPHROPATHY AT WELLINGTON HOSPITAL: A RETROSPECTIVE REVIEW
 Chembo C, Leikis M, Pidgeon G, Hay N, Matheson P, Macdonald A
  046 ATYPICAL CASES OF PAUCI-IMMUNE GLOMERULONEPHRITIS AT ROYAL BRISBANE AND WOMEN'S HOSPITAL
 Mallett A, Ranganathan D, John G, D’Intini V, Francis L, Healy H
  047 OUTCOMES OF ANCA ASSOCIATED VASCULITIS TREATED WITH THERAPEUTIC PLASMA EXCHANGE AND IMMUNOSUPPRESSION
 Nayar S, Mudie K, John G, Ranganathan D
  048 SERONEGATIVE ANTI-GLOMERULAR BASEMENT MEMBRANE (GBM) DISEASE: A CASE SERIES ILLUSTRATING CLINICAL AND PATHOLOGICAL CHARACTERISTICS
 Ducharlet K, Tan S, Hill P, Langham R
  049 RESOLUTION OF DIALYSIS-REQUIRING ACUTE KIDNEY INJURY IN A CASE OF MINIMAL CHANGE DISEASE: IMMUNOSUPPRESSION OR NEPHROSARCA?
 Mallett A, Ratanjee S, John G, Francis L, Healy H
  050 RENAL OUTCOME IN ANCA VASCULITIS IS DETERMINED BY PRESENTING CREATININE AND GLOMERULAR HISTOLOGICAL INJURY
 Ford S, Polkinghorne K, Longarno A, Dowling J, Kerr P, Holdsworth S, Kitching R, Summers S
  051 PREVALENCE AND ASSOCIATIONS OF PROTEINURIA IN AUSTRALIAN SCLERODERMA PATIENTS: A RETROSPECTIVE REVIEW
 Hutton H, Sahhar J, Ngian G, Kerr P, Polkinghorne K
  052 REVIEW OF RENAL PARENCHYMAL DISEASE PATTERN IN INDONESIA: A RENAL BIOPSY STUDY
 Hustrini N, Lydia A
  053 NODULAR GLOMERULOSCLEROSIS IN CYSTIC FIBROSIS MIMICKING DIABETIC NEPHROPATHY – A NEW APPRAISAL OF AN OLD PROBLEM
 O'Shea S, Mallett A
  054 A CASE SERIES OF ANTI-GLOMERULAR BASEMENT MEMBRANE ANTIBODY DISEASE – TREATMENT AND OUTCOMES
 O'Shea S, Mudie K, Francis R, Kennedy G, Ranganathan D
1400–1530 ORAL MINI-POSTERS 4
  Experimental Immunology & Developmental Biology
  Co-Chairs: A/Prof Alan Davidson, Dr Sean Summers
  055 AIRE IN THE MAINTENANCE OF CENTRAL TOLERANCE TO MYELOPEROXIDASE AND THE DEVELOPMENT OF AUTOIMMUNE ANTI- MYELOPEROXIDASE GLOMERULONEPHRITIS
 Gan P, Tan D, Hammett M, Chidgey A, Boyd R, Scott H, Ardesjo Lundgren B, Summers S, Kitching A, Holdsworth S
  056 IDENTIFICATION OF FOUR MAJOR SUBSETS OF RENAL MONONUCLEAR PHAGOCYTES IN HEALTHY AND DISEASED KIDNEY
 Cao Q, Wang M, Alexander S, Wang Y, Harris D
  057 LPS-INDUCED ALBUMINURIA IS DEPENDENT UPON JNK SIGNALLING
 Ho J, Ozols E, Ma F, Bennett B, Nikolic-Paterson D
  058 RENAL ANTIGEN RECOGNITION THROUGH THE TCR MEDIATES THE PROTECTIVE EFFECTS OF CD4+CD25+REGULATORY T CELLS IN ADRIAMYCIN NEPHROPATHY
 Wang Y, Wang Y, Wang Y, Zheng G, Tan T, Lee S, Zhang J, Zhang G, Hu M, Wang C, Yu X, Cao Q, Burgess J, Alexander S, Harris D
  059 DENDRITIC CELL TARGETING ENHANCES THE EFFICACY OF CD40 DNA VACCINE IN HEYMANN NEPHRITIS
 Wang Y, Wang Y, Wang Y, Zheng G, Zhang G, Zhou J, Tan T, Cao Q, Hu M, Zheng D, Wu H, Harris D, Alexander S
  060 MIR-200B PREVENTS TGFB1-INDUCED FIBROTIC AND INFLAMMATION RESPONSE IN KIDNEY PROXIMAL TUBULAR CELLS
 Tang O, Chen X, Pollock C
  061 EXACERBATION OF SPONTANEOUS AUTOIMMUNE NEPHRITIS FOLLOWING REGULATORY T CELL DEPLETION IN BIM KNOCKOUT MICE
 Wang Y, Zhang G, Wang Y, Hu M, Zhou J, Saito M, Sawyer A, Polhill T, Wang Y, Zheng G, Lee V, Harris D, Alexander S
  062 DEFICIENCY OF LIMP-2, AN INTEGRAL LYSOSOMAL PROTEIN, ATTENUATES RENAL INJURY IN EXPERIMENTAL CRESCENTIC GLOMERULONEPHRITIS
 Lee D, Gan P, Katerelos M, Fraser S, Gleich K, Tipping P, Thomas M, Holdsworth S, Power D
  063 SPONTANEOUS IMMUNE COMPLEX DEPOSITION AND PROTEINURIA IN THE COMMON MARMOSET MONKEY (CALLITHRIX JACCHUS) – A MODEL OF BENIGN NON-PROGRESSIVE GLOMERULOPATHY
 Collins M, Rogers N, Jesudason S, Kireta S, Brealey J, Coates T
  064 THE REGENERATIVE POTENTIAL OF MESENCHYMAL STEM CELLS FOLLOWING ISCHEMIA-REPERFUSION INJURY
 Wise A, Williams T, Zhuang J, Samuel C, Ricardo S
  065 THE USE OF ANTI-CSF-1R AND ANTI-GM-CSF ANTIBODIES TO MODULATE INFLAMMATION IN ISCHEMIA/REPERFUSION INJURY
 Williams T, Layton D, Samuel C, Hamilton J, Ricardo S
  066 PODOCYTE SPECIFIC DELETION OF CRIM1 LEADS TO GLOMERULAR FILTRATION BARRIER DEFECTS
 Wilkinson L, Neal C, Stephanie A, Pennisi D, Little M
  067 THROMBIN AND PAR-1 REGULATE SPHINGOSINE KINASES 1 AND 2 AND SPHINGOSINE-1-PHOSPHATE RECEPTORS FOLLOWING RENAL IRI
 She G, Chuang A, Kennedy S, Erlich J
1530–1600 AFTERNOON TEA AMONGST EXHIBITION
1600–1730 KIDNEY HEALTH AUSTRALIA CLINICAL SCIENCE AWARD
  Chair: A/Prof Timothy Mathew
  068 4-HOUR CREATININE CLEARANCE IN THE INTENSIVE CARE UNIT
 Pickering J, Frampton C, Walker R, Shaw G, Endre Z
  069 THE DISEASE CHARACTERISTICS OF ANCA ASSOCIATED VASCULITIS: 735 PATIENTS RECRUITED AT DIAGNOSIS TO SIX EUROPEAN VASCULITIS STUDY GROUP TRIALS
 Yew S, Jayne D, Hoglund P, Westman K, Luqmani R
  070 ALBUMINURIA AS A RISK FACTOR FOR CARDIOVASCULAR DISEASE AND END STAGE RENAL DISEASE (ESRD) IN TYPE 2 DIABETES
 Collins J, Elley C, Kenealy T, Moyes S, Drury P
  071 LONG TERM OUTCOMES OF SEVERE AKI: RESULTS OF THE POST-RENAL STUDY
 Gallagher M, Bellomo R, Cass A, Finfer S, Gattas D, Lee J, Lo S, McGuinness S, Myburgh J, Parke R, Rajbhandari D
  072 PREVALENCE OF EARLY MARKERS FOR CHRONIC KIDNEY AND CARDIOVASCULAR DISEASE IN ABORIGINAL AND NON-ABORIGINAL CHILDREN: RESULTS OF 6 YEAR POPULATION BASED COHORT STUDY
 Kim S, Sureshkumar P, Hodson E, Williams R, Vukasin N, Kearns R, Haysom L, Lyle D, Craig J
  073 THE APOL1 GENOTYPE IN AFRICAN AMERICANS IS ASSOCIATED WITH GLOMERULAR, RENAL AND CARDIAC HYPERTROPHY, AS WELL AS HYPERTENSION AND CARDIOVASCULAR DISEASE
 Hoy W, Hughson M, Winkler C, Douglas-Denton R, Mott S, Bertram J, Kopp J
1600–1730 SEMINAR 2: BASIC SCIENCE
 Genetic determinants of macrophage activation in glomerulonephritis
  Prof Terry Cook
  Imperial College London, UK
 Gas (NH3) transport by Rhesus proteins – it is not just hot air, it is necessary for normal functioning
  Prof David Weiner
  University of Florida, FL, USA
 Advanced glycaton end products: pathological mediators or just biomarkers in diabetic renal disease?
  A/Prof Josephine Forbes
  Mater Medical Research Institute, Brisbane, QLD
  Chair: Prof David Nikolic-Paterson
1730 ANZSN ANNUAL GENERAL MEETING
1830 WELCOME RECEPTION

TUESDAY 28 AUGUST 2012

0830–0930 PLENARY SESSION 2
 Clinical and biological correlates of operational tolerance of kidney allografts
  Prof Jean-Paul Soulillou
  Chair: A/Prof Toby Coates
  Proudly sponsored by Novartis and Jannsen-Cilag
0930–1100 ANZDATA SESSION
  Chairs: Prof Steven Chadban, A/Prof Stephen McDonald
 What's happening at ANZDATA
  Prof Steven Chadban
 Socioeconomic status, transplantation and waiting lists
  Dr Blair Grace
 Deceased donor kidney allocation
  Dr Phil Clayton
 Survival on dialysis after myeloma
  Dr Angela Webster
 Indigenous transplant outcomes
  Prof Matthew Jose
 PD fluids – which, who, where, when
  Dr Fiona Brown
0930–1100 SEMINAR 3: SYSTEMS BIOLOGY IN KIDNEY DISEASE
 Of mice and men – NMR-based metabolomics between systems biology and clinical science
  Dr Horst Joachim Schirra
  University of Queensland, Brisbane, QLD
 Recent advances in peptidomic profiling and the development of in vitro diagnostics
  Prof Gregory Rice
  University of Queensland, Brisbane, QLD
 Assessing the metabolomic state of cells and tissues through metabolomics
  Dr Silas Villas-Boas
  University of Auckland, Auckland, New Zealand
  Chair: A/Prof Sharon Ricardo
1100–1130 MORNING TEA AMONGST THE EXHIBITION
1130–1300 ORAL MINI-POSTERS 5
  Haemodialysis
  Co-Chairs: Dr Vincent Lee, A/Prof Nigel Toussaint
  074 HIGH CUT-OFF HAEMODIALYSIS INCREASES URAEMIC TOXIN REMOVAL
 Gondouin B, Bevins A, Cockwell P, Vanholder R, Hutchison C
  075 THE CARBON FOOTPRINT OF A SATELLITE HAEMODIALYSIS UNIT IN VICTORIA
 Lim A, Perkins A, Agar J
  076 RESPITE HEMODIALYSIS TO REMOTE INDIGENOUS CENTRAL AUSTRALIAN POPULATION AND MOBILE DIALYSIS UNIT
 Shashi Bhaskara S, Cherian S, Pawar B, Fernandes D, Sureshkumar R, Gosling C
  077 CLINICIAN BELIEFS AND ATTITUDES ABOUT HOME HAEMODIALYSIS: QUALITATIVE INTERVIEW STUDY
 Tong A, Palmer S, Manns B, Craig J, Ruospo M, Gargano L, Johnson D, Strippoli G
  078 DIALYSIS PATIENTS BENEFIT FROM PSYCHOLOGICAL AND EXERCISE INTERVENTION
 McMahon L, Cai M, Baweja S, Kent A, Clements A, Reilly R, Taylor N, Holt S
  079 CHANGES IN QTC INTERVAL AND QTC DISPERSION BETWEEN LONG (72 HOUR) VERSUS SHORT (48 HOUR) INTERDIALYTIC BREAK IN CHRONIC HAEMODIALYSIS PATIENTS
 Hidayati L, Marasovic S, Nand K, Cox N, Nelson C
  080 TRIAL OF A TRANSPORTABLE LOW DIALYSATE VOLUME HOME HAEMODIALYSIS SYSTEM
 Killen J, Baer R, Mantha M, Hakim H, Srivastava V
  081 PREVENTION OF HAEMODIALYSIS ACQUIRED HEPATITIS B VIRUS INFECTION IN A REGIONAL AND REMOTE NORTHERN AUSTRALIAN ENDEMIC POPULATION
 Jabbar Z, Davies J, Gagan F, Baird R
  082 ANTI-HELMINTHIC TREATMENT IN A HAEMODIALYSIS POPULATION WITH EOSINOPHILIA
 Tan S, Manickam V, Kan G
  083 FUNCTIONAL STATUS OF END-STAGE RENAL PATIENTS ON DIALYSIS AT WESTMEAD AND BLACKTOWN HOSPITALS DIALYSIS CENTERS
 Marosszeky J, Samson J
  084 WHEN IS THE IDEAL TIME TO START A HOME BASED DIALYSIS THERAPY?
 Cooper B, Wong M, Branley P, Harris D, Collins J, Craig J, Fraenkel M, Harris A, Kesselhut J, Li J, Luxton G, Pilmore A, Tiller D, Johnson D, Pollock C
  085 EFFECTS OF DIALYSATE SODIUM REDUCTION ON WEIGHT GAIN AND BLOOD PRESSURE IN HAEMODIALYSIS PATIENTS: A PILOT STUDY
 Pan F, Cai M, Kent A, Clements A, Holt S, McMahon L
  086 THE SURVIVAL BENEFIT OF OBESITY ATTENUATES OVER TIME AMONG HAEMODIALYSIS PATIENTS
 McDonald S, Marshall M, Polkinghorne K
  087 NXSTAGE QUEENSLAND HEALTH PILOT PROGRAM THE EARLY AUSTRALIAN NXSTAGE EXPERIENCE: IS NXSTAGE REALLY THE NEXT STAGE IN HOME HAEMODIALYSIS?
 Lee A, Killen J, Hawley C, Jeffries J, Equinox K, Johnson D, Campbell S, Isbel N, Mudge D, Badve S, Van Eps C
  088 NUTRITION AND HEAMODIALYSIS: THE IMPACT OF DIETITIAN INTERVENTION UPON ACHIEVING QUALITY PATIENT DIALYSIS OUTCOMES IN THE KINGDOM OF SAUDI ARABIA
 Bunani A, Sedgewick J, Lehbi A
  080 3 YEAR FOLLOW-UP OF VITAMIN D DEFICIENCY IN PREVALENT AUSTRALIAN DIALYSIS PATIENTS
 Singer R, Clayton P
1130–1300 ORAL MINI-POSTERS 6
  Chronic Kidney Disease 1
  Co-Chair: Dr David Semple, Prof Rowan Walker
  090 SALIVA COMPOSITION AND UPPER GASTRO-INTESTINAL SYMPTOMS IN CHRONIC RENAL DISEASE
 Manley K
  091 AN AUDIT OF OUTCOMES IN LATE REFERRAL PATIENTS WITH CHRONIC KIDNEY DISEASE
 Knagge D, Hoopman S, Buxton E, McCaughan G, McGinn S
  092 CLINICAL PKD1 SEQUENCING IN QUEENSLAND
 Kozlov S, Mallett A, Woods R, Healy H, Rowell J, McGaughran J, Hyland V
  093 PREVENTION, DETECTION, AND MANAGEMENT OF EARLY CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW OF CLINICAL PRACTICE GUIDELINES
 Lopez-Vargas P, Tong A, Sureshkumar P, Johnson D, Craig J
  094 EFFECTIVE PREDIALYSIS EDUCATION CAN BE DELIVERED IN A RURAL SETTING
 Al-Moktar M, Holmes C, Stevenson E
  095 PSYCHOSOCIAL FACTORS (DEPRESSION, ANXIETY AND SOCIAL ISOLATION) AND THEIR INFLUENCE ON THE PROGRESSION OF CHRONIC KIDNEY DISEASE AND USE OF KIDNEY REPLACEMENT THERAPY
 McKercher C, Venn A, Blizzard L, Nelson M, Palmer A, Ashby M, Scott J, Jose M
  096 SEARCH STRATEGIES FOR LOCATING DIAGNOSTIC TEST ACCURACY (DTA) STUDIES IN NEPHROLOGY JOURNALS
 Ladhani M, Togerson T, Mitchel R, Craig J, Webster A
  097 ASSESSMENT OF NEPHROLOGIST REFERRALS – PREVENTING BURNOUT
 Pirabhahar S, Robins J, Katz I
  098 COGNITIVE FUNCTION, HEALTH DECISION MAKING AND OUTCOMES IN PEOPLE WITH EGFR 15–29?MLS/MIN/1.73?M2
 McKercher C, Venn A, Blizzard L, Nelson M, Palmer A, Ashby M, Scott J, Jose M
  098 PATIENT INFORMATION ABOUT OPTIONS FOR TREATMENT (PINOT) FOLLOW UP STUDY: ANSWERING IMPORTANT QUESTIONS IN HOME DIALYSIS AND CONSERVATIVE CARE
 Morton R, Connolly M, Snelling P, Gray N, Webster A, McGeechan K, Howard K, Kerr P
  100 QUALITATIVE STUDY INVESTIGATING HOW HEALTHCARE PROVIDERS AND PEOPLE WITH CHRONIC KIDNEY DISEASE (CKD) VIEW DIALYSIS
 Lloyd B, Jose M
  101 A STUDY OF PATTERN OF EMPHYSEMATOUS AND NON EMPHYSEMATOUS PYELONEPHRITIS AMONGST HOSPITALIZED TYPE 2 DIABETES MELLITUS PATIENTS
 Kohli H, Ramachandran R, Kumar S, Sakhuja V
1130–1300 ORAL MINI-POSTERS 7
  Acute Kidney Injury & Renal Disease in Pregnancy
  Co-Chairs: Prof Zoltan Endre, A/Prof Helen Pilmore
  102 RENAL DISORDERS INDUCED BY MATERNAL SMOKING
 Saad S, Chen H, Al-Odat I, Killingsworth M, Pollock C
  103 TRANSIENT ACUTE KIDNEY INJURY (AKI) IS COMMON FOLLOWING SIGNIFICANT RENAL HYPOPERFUSION
 Md Ralib A, Pickering J, Shaw G, Than M, Endre Z
  104 ACE INHIBITOR FETOPATHY: A CASE SERIES AND SURVEY OF CURRENT PRACTICE AMONGST NEW ZEALAND PAEDIATRICIANS, OBSTETRICIANS, NEONATOLOGISTS AND NEPHROLOGISTS
 Deva M, Kara T
  105 NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN (NGAL) AND RENAL IMPAIRMENT AFTER NON-CARDIAC SURGERY
 Mooney J, Chow C, Trivedi S, Barzi F, Jagnoor J, Wilson S, Li S, Clough M, Hillis G, Halliwell R, Lee V
  106 UNDER-REFERRAL OF AKI TO NEPHROLOGICAL SERVICES
 Feher E, Lim E, Chakera A
  107 RHABDOMYOLYSIS. A RETROSPECTIVE CASE SERIES: CAUSES AND OUTCOMES
 Sampson A, Talaulikar G
  108 METABOLIC ACIDOSIS: AN EARLY MARKER OF ACUTE KIDNEY INJURY IN ICU?
 Gujadhur A, Tiruvoipati R, Wong K
  109 A PROSPECTIVE OBSERVATIONAL STUDY OF HAEMATURIA AND ACUTE KIDNEY INJURY IN ELDERLY PATIENTS PRESENTING TO HOSPITAL WITH SUPRATHERAPEUTIC ANTICOAGULATION WITH WARFARIN
 Lim A, Campbell D
  110 THE TTP REGISTRY: INITIAL DATA FROM A NEW REGISTRY
 Isbel N, Wilkins S, Sloane J, Phillips L, Cannell P, Davies C, Engelbrecht S, Hsu D, McQuilten Z, Opat S, Roxby D, Wood E, Cohney S
  111 EARLY REDUCTIONS IN FREE LIGHT CHAIN CONCENTRATIONS IMPROVE OUTCOMES IN MYELOMA KIDNEY: AN INTERNATIONAL STUDY
 Bevins A, Cook M, Cockwell P, Hutchison C
  112 POLYCLONAL FREE LIGHT CHAINS AS A PREDICTOR OF SURVIVAL IN CKD
 Hutchison C, Bevins A, Church H, Stringer S, Harding S, Cockwell P
  113 CRITERIA FOR FLC REMOVAL BY HAEMODIALYSIS IN MYELOMA KIDNEY
 Hattersley J, Hutchison C
1130–1300 ORAL MINI-POSTERS 8
  Experimental Tubulointerstitial Disease 1
  Co-Chairs: Dr Usha Panchapakesan, Dr Greg Tesch
  114 SOLID ORGAN FIBROSIS: EVIDENCE FOR A COMMON PATHWAY ACROSS SPECIES!
 Marti H, Jeffs A, Bedford J, Scherer A, Walker R
  115 REGULATION OF MATRIX METALLOPROTEINASES IN THE KIDNEY: ROLE OF RELAXIN AND NITRIC OXIDE
 Chow B, Hewitson T, Samuel C
  116 A NOVEL GLUTATHIONE PEROXIDASE (GPX) MIMIC ATTENUATES DIABETIC NEPHROPATHY IN GPX1/ APOE DOUBLE KNOCKOUT MICE
 Tan S, Sharma A, Stefanovic N, de Haan J
  117 TELEMETRY-BASED OXYGEN SENSOR TO CONTINUOUSLY MONITOR KIDNEY OXYGENATION IN CONSCIOUS RATS
 Koeners M, Ow C, Abdelkader A, Evans R, Russell D, Malpas S
  118 REGULATION OF NKCC1 BY AMP-ACTIVATED PROTEIN KINASE (AMPK)
 Davies M, Katerelos M, Fraser S, Gleich K, Mount P, Power D
  119 RAPID CHANGES IN RENIN AND LEPTIN LEVELS FOLLOWING CHANGE OF DIET IN OBESE MICE
 Davies M, Fraser S, Katerelos M, Gleich K, Mount P, Power D
  120 LIMP-2, A LYSOSOMAL MEMBRANE PROTEIN, IS EXPRESSED IN RENIN SECRETORY GRANULES, AND INHIBITS PROTEOLYTIC CONVERSION OF PRORENIN TO RENIN
 Lee D, Fraser S, Katerelos M, Gleich K, Power D
  121 TUBULAR PROTEINURIA INDUCED BY ALBUMIN OVERLOAD IS NOT DUE TO REDUCED UPTAKE BUT REFLECTS THE LIMITED CAPACITY OF LYSOSOMAL DEGRADATION IN THE PROXIMAL TUBULE
 Lee D, Fraser S, Katerelos M, Gleich K, Thomas M, Mount P, Power D
  122 LINAGLIPTIN REDUCES HIGH GLUCOSE INDUCED INFLAMMATORY AND FIBROTIC MARKERS IN HUMAN KIDNEY PROXIMAL TUBULAR CELLS
 Panchapakesan U, Komala M, Mather A, Pegg K, Gross S, Pollock C
  123 LEPTIN ALTERS TUBULAR HANDLING OF ALBUMIN
 Briffa J, Hryciw D
  124 INCREASING ANTI-APOPTOTIC NUCLEOLAR PROTEIN-3 CORRELATES WITH CANCER PROGRESSION IN RENAL CELL CARCINOMA
 Rajandram R, Gobe G, Wang Z, Vesey D, Johnson D, Morais C
1300–1400 LUNCH AMONGST THE EXHIBITION
1400–1530 BASIC SCIENCE AWARD
  Co-Chairs: A/Prof Glenda Gobe, A/Prof Timothy Hewitson
  125 THE ROLE OF FXR IN RENAL DISEASES AND ASSOCIATED METABOLIC DISORDERS AFFECTING OFFSPRING IMPACTED BY MATERNAL OBESITY
 Saad S, Chen H, Pollock C, Wong M
  126 HMGB1 PRECONDITIONING PROTECTS AGAINST KIDNEY ISCHEMIA REPERFUSION INJURY
 Wu H, Steenstra R, C.S.de Boer E, Zhao C, MA J, O’Brien M, Chadban S
  127 BLOCKADE OF SPLEEN TYROSINE KINASE (SYK) ATTENUATES RENAL FIBROSIS IN RAT UNILATERAL URETERIC OBSTRUCTION
 Ma F, Blease K, Nikolic-Paterson D
  128 THE IMMUNODOMINANT T CELL GOODPASTURE EPITOPE INDUCES ANTI-GLOMERULAR BASEMENT MEMBRANE GLOMERULONEPHRITIS IN SUSCEPTIBLE HLA-DR TRANSGENIC MICE
 Kitching A, Chang J, Holdsworth S, Ooi J
  129 ENDOGENOUS TOLL LIKE RECEPTOR 9 REGULATES ACUTE KIDNEY INJURY
 Summers S, Ford S, Ghali J, Kitching A, Holdsworth S
  130 REPROGRAMMING HUMAN KIDNEY CELLS TO GENERATE PODOCYTE PROGENITORS: APPLICATIONS FOR DISEASE MODELING AND CELLULAR REPLACEMENT
 Ricardo S, Song B, Smink A, Jones C, O’Neill A, Laslett A, Kerr P
1400–1530 SEMINAR 4: CLINICAL SCIENCE
 What is the role of the gut in the pathophysiology of chronic kidney disease?
  A/Prof Christopher McIntyre
  Univeristy of Nottingham, UK
 Is there a future for biochemical markers of cardiovascular disease in CKD and ESKD?
  Dr Matthew Roberts
  Austin Health, Melbourne, VIC
 Renal denervation in CKD: mechanisms, current findings and future prospects
  A/Prof Markus Schlaich
  Baker IDI Heart and Diabetes Institute, Melbourne, VIC
  Chair: A/Prof Mark Marshall
1600–1730 ORAL MINI-POSTERS 9
  Peritoneal Dialysis
  Co-Chairs: A/Prof John Collins, Dr Steve May
  131 FUNGAL PERITONITIS IN CONTINUOUS AMBULATORY PERITONEAL DIALYSIS COHORT IN THE NORTHERN TERRITORY
 Cluney B, Sundaram M, Lawton P, Majoni W, Shaw M, Jabbar Z, Perry G
  132 PERITONEAL DIALYSIS OUTCOMES IN A REGIONAL AND REMOTE NORTHERN AUSTRALIAN POPULATION: A TEN YEAR SINGLE-CENTRE RETROSPECTIVE COHORT STUDY
 Sundaram M, Shaw M, Majoni S, Perry G, Jabbar Z
  133 RADIOLOGICAL INSERTION OF TENCKHOFF CATHETERS FOR PERITONEAL DIALYSIS
 Quach T, Tregaskis P, Koukounaras J, Walker R
  134 ROLE OF RESIDUAL RENAL FUNCTION AND MEMBRANE TRANSPORTER TYPE IN PERITONEAL DIALYSIS ADEQUACY
 Barraclough N, Gock H, O’Flaherty E
  135 THE PERSPECTIVES OF ADULTS LIVING WITH PERITONEAL DIALYSIS: THEMATIC SYNTHESIS OF QUALITATIVE STUDIES
 Lesmana B, Tong A, Johnson D, Wong G, Campbell D, Craig J
  136 PERITONEAL DIALYSIS IN RURAL AUSTRALIA
 Gray N, Grace B, McDonald S
  137 CATHETER & INFECTION-FREE SURVIVAL OF DIFFERENT PERITONEAL DIALYSIS CATHETER INSERTION TECHNIQUES
 Nguyen T, Lam-Po-Tang M, Beechey D, Marshall M, Voss D
  138 NON-CANDIDAL FUNGAL PERITONITIS IN FAR NORTH QUEENSLAND: A CASE SERIES
 Baer R, Killen J, Cho Y, Mantha M
  139 POST-OPERATIVE OUTCOMES OF THREE DIFFERENT TECHNIQUES OF PERITONEAL DIALYSIS CATHETER INSERTION
 Nguyen T, Voss D, Marshall M, Beechey D, Lam-Po-Tang M
  140 INTRAPERITONEAL UROKINASE FOR THE RELAPSING PERITONITIS IN PERITONEAL DIALYSIS PATIENTS
 Sizeland P, Ly E, Waters G, Wong A
  141 ENCAPSULATING PERITONEAL SCLEROSIS: A NEW ZEALAND CENTRE'S TEN-YEAR EXPERIENCE
 Sizeland P, Walker C, Hamilton D, Fisher M
  142 A CLUSTER OF CANDIDA GUILLERMONDII PERITONITIS FOLLOWING Y-TECTM PERITONEOSCOPIC PERITONEAL CATHETER INSERTION
 Wong J, Nagendra V, Maley M, Meyer W, Suryanarayanan G, Suranyi M, Spicer T, Aravindan A
  143 A NOVEL ADAPTATION OF DISPOSABLE VERESS NEEDLES FOR PERCUTANEOUS PERITONEAL DIALYSIS CATHETER INSERTION USING THE SELDINGER METHOD VIA A PERITONEAL SINGLE PUNCTURE
 Wong J, Suryanarayan G, Spicer T, Jefferys A, Howlin K, Cleland B, Hall B, Makris A, Suranyi M, Aravindan A
  144 PERCUTANEOUS PERITONEAL DIALYSIS CATHETER INSERTION USING A MICROPUNCTURE ASSISTED SELDINGER METHOD UNDER ULTRASOUND AND FLUOROSCOPIC GUIDANCE – A BRIEF EXPERIENCE
 Wong J, Suryanarayan G, Spicer T, Jefferys A, Howlin K, Cleland B, Hall B, Makris A, Suranyi M, Aravindan A
  145 NEPHROLOGIST INSERTED PERITONEAL DIALYSIS(PD) CATHETER, SINGLE CENTRE EXPERIENCE FROM A REGIONAL HOSPITAL, NSW, AUSTRALIA
 Khafaji M, Pollock C, McLaren C
  146 DOES AGE OF THE PATIENT AFFECT PERITONEAL DIALYSIS?
 Bernuy J, Nayar S, John G, Ranganathan D
  147 Y-TECTM PERITONEOSCOPIC PERITONEAL DIALYSIS CATHETER INSERTION AT LIVERPOOL HOSPITAL – A 5 YEAR EXPERIENCE
 Wong J, Suryanarayanan G, Spicer T, Jefferys A, Howlin K, Cleland B, Hall B, Makris A, Suranyi M, Aravindan A
1600–1730 ORAL MINI-POSTERS 10
  Chronic Kidney Disease 2
  Co-Chairs: Dr Meg Jardine, Prof Kelvin Lynn
  148 GLOMERULAR VOLUME ESTIMATES IN A NATIONWIDE STUDY OF AUSTRALIAN INDIGENOUS PEOPLE
 Hoy W, Samuel T, Mott S, Kincaid-Smith P, Fogo A, Dowling J, Hughson M, Sinniah R, Pugsley D, Kirubakaran M, Douglas-Denton R, Bertram J
  149 ACCURATE ASSESSMENT OF KIDNEY FUNCTION IN INDIGENOUS AUSTRALIANS: THE EGFR STUDY
 Maple-Brown L, Huges J, Lawton P, Jones G, Ellis A, Drabsch K, Cass A, Hoy W, MacIsaac R, O'Dea K, Jerums G
  150 TOTAL INCIDENCE OF END-STAGE KIDNEY DISEASE IN AUSTRALIA, 2005–2007: REMOTENESS AND SOCIOECONOMIC STATUS
 Sparke C, Green F, O’Mahony S, Moon L
  151 MAYBE MERCURY IS NOT ALWAYS GOLD
 Lan P, Gillin A
  152 A PROGRESS REPORT ON A RANDOMISED CONTROLLED TRIAL (RCT) OF PHARMACOLOGIC PREVENTION OF RENAL DISEASE, DIABETES AND HYPERTENSION IN A HIGH RISK REMOTE ABORIGINAL COMMUNITY
 Hoy W, Mott S, McLeod B, Sharma S, Godfrey J, Heaslop C, Alcock G, Montz A, Nixon C, Pilakui N, Bourke C, Guy D, Guy M, Ullungurra B, Tipiloura E
  153 ENQUIRY INTO GENETIC ASSOCIATIONS OF RENAL AND RELATED CHRONIC DISEASE IN TIWI ABORIGINAL PEOPLE
 Hoy W, Karu N, Foote S, Mathews J, Thomson R, McMorran B, Hilder E, Shellie R, Jose M
  154 EARLY LIFE RISK FACTORS STRONGLY INFLUENCE RENAL DISEASE RISK IN REMOTE ABORIGINAL AUSTRALIANS
 Hoy W, Singh G, White A, Mathews J, Swanson C, Sharma S, Bloomfield H, McCredie D
  155 CHANGES IN PROCESS MEASURES ARISING OUT OF A CHRONIC DISEASE PRACTICE IMPROVEMENT INITIATIVE IN A REMOTE CENTRAL AUSTRALIAN ABORIGINAL COMMUNITY
 Hoy W, Swanson C, Hope A, Smith J, Masters C
  156 CHRONIC DISEASE PROFILES AND TREATMENT IN A REMOTE CENTRAL AUSTRALIAN ABORIGINAL COMMUNITY
 Hoy W, Swanson C, Hope A, Smith J, Masters C
  157 CHRONIC KIDNEY DISEASE (CKD): INNOVATION, COLLABORATION AND EDUCATION IN GENERAL PRACTICE
 Ludlow M, Robson B, Mathew T
  158 HIGHER, BUT NOT TOXIC SERUM COBALT CONCENTRATIONS IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND WELL FUNCTIONING JOINT REPLACEMENTS
 Cai M, McMahon L, Al-Saada A, Smith E, Wilson D, Holt S
  159 FLYING NEPHROLOGISTS – REMOTE RENAL OUTREACH CLINICS IN THE TOP END
 Chalmers R, Sundaram M, Majoni W, Jabbar Z, Perry G
1600-1730 ORAL MINI-POSTERS 11
  Transplantation 1
  Co-Chairs: Dr Nick Cross, Dr Germaine Wong
  160 PROPHYLAXIS OF CYTOMEGALOVIRUS (CMV) DISEASE IN SOLID ORGAN TRANSPLANT RECIPIENTS: A SYSTEMATIC REVIEW
 Ladhani M, Hodson E, Webster A, Strippoli G, Craig J
  161 PRE-EMPTIVE TREATMENT FOR CYTOMEGALOVIRUS VIRAEMIA TO PREVENT CYTOMEGALOVIRUS DISEASE IN SOLID ORGAN TRANSPLANT RECIPIENTS – A SYSTEMATIC REVIEW OF RANDOMISED CONTROLLED TRIALS
 Webster A, Owers D, Hodson E, Kable K, Strippoli G
  162 HIGH TRANSPLANT RATES OF HIGHLY-SENSITIZED RECIPIENTS WITH VIRTUAL CROSSMATCHING IN KIDNEY PAIRED DONATION
 Ferrari P, Fidler S, Woodroffe C, Tassone G, D’Orsogna L
  163 LUMINEX ANTIBODY THRESHOLD TO MATCH DONOR-RECIPIENT PAIRS USING VIRTUAL CROSSMATCH IN KIDNEY PAIRED DONATION
 Ferrari P, Fidler S, Woodroffe C, D’Orsogna L
  164 COMPARISON OF TIME ON THE CADAVERIC KIDNEY DONOR WAITLIST VERSUS TIME ON THE KIDNEY PAIRED DONATION REGISTRY
 Ferrari P, Fidler S, Woodroffe C, D’Orsogna L
  165 COMPARISON OF HLA MATCHING AND EPITOPE MATCHING USING VIRTUAL CROSSMATCH IN KIDNEY PAIRED DONATION
 Ferrari P, Fidler S, Woodroffe C, D’Orsogna L
  166 A PROSPECTIVE TRIAL OF DIET AND EXERCISE TO IMPROVE GLUCOSE METABOLISM AND CARDIOVASCULAR RISK FOR DE NOVO KIDNEY TRANSPLANT RECIPIENTS TREATED WITH TACROLIMUS-BASED IMMUNOSUPPRESSION
 Chadban S, Whitman G, Wyburn K, Butcher B, Rees T, Russ G, Mulley W, Irish A, Dunstan D, Eris J
  167 BLOOD GROUP A IS ASSOCIATED WITH POORER SURVIVAL AFTER DECEASED DONOR RENAL TRANSPLANTATION
 Mallett A, Isbel N, John G, Clayton P, Campbell S
  168 FACTORS INFLUENCING ACCEPTANCE OF NOMS ALLOCATED KIDNEYS: THE IMPACT OF DONOR SPECIFIC ANTIBODIES
 Chan C, Cantwell L, Cummrow M, Opdam H, Polkinghorne K, Mulley W, Kanellis J
  169 PRODUCTION RATES OF FREE LIGHT CHAINS PREDICT INFECTIONS POST-TRANSPLANT
 Shabir S, Bevins A, Church H, Borrows R, Hutchison C
  170 THE IMPACT OF PROTON PUMP INHIBITOR CO-MEDICATION ON MYCOPHENOLIC ACID EXPOSURE EARLY POST-KIDNEY TRANSPLANT
 Barraclough K, Isbel N, Lee K, Johnson D, Campbell S, Leary D, Staatz C
  171 A PICTURE OF DIALYSIS AND KIDNEY TRANSPLANTATION STATISTICS IN AUSTRALIA
 O’Mahony S, Green F, Sparke C
  172 RISK-FACTOR PROFILE OF LIVING KIDNEY DONORS: THE ANZDATA LIVING KIDNEY DONOR REGISTRY 2004–2010
 Clayton P, McDonald S, Allen R, Pilmore H, Saunder A, Chadban S
  173 DIAGNOSTIC ACCURACY OF QUANTITATIVE VIRAL TESTING FOR POLYOMA VIRUS-ASSOCIATED NEPHROPATHY IN KIDNEY AND KIDNEY PANCREAS TRANSPLANT RECIPIENTS
 Myint TM, Webster A, Cross N, Kable K, Nankivell B, Craig J, Chapman J, Wong G
  174 DETERMINANTS OF PREEMPTIVE AND LIVE KIDNEY TRANSPLANTATION IN CHILDREN
 Grace B, Kennedy S
  175 ACCESS TO THE AUSTRALIAN DECEASED-DONOR KIDNEY WAITING LIST
 Grace B, Clayton P, McDonald S, Chapman J, Wright J, Slater P, Russ G
1530–1600 ORAL MINI-POSTERS 12
  Experimental Tubulointerstitial Disease 2
  Co-Chairs: A/Prof Timothy Hewitson, Dr Gopi Rangan
  176 PHARMACOLOGICAL INHIBITION OF NADPH OXIDASE (NOX1/NOX4) AMELIORATES ALBUMINURIA AND KIDNEY DAMAGE IN STREPTOZOTOCIN INDUCED DIABETIC APOE KO MICE
 Jha J, Gray S, Page P, Szyndralewiez C, Heitz F, Wiesel P, Cooper M, Jandeleit-Dahm K
  177 EFFECTS OF PARICALCITOL ON THE PROGRESSION OF POLYCYSTIC KIDNEY DISEASE AND HYPERTENSION IN RATS
 Schwensen K, Harris D, Rangan G
  178 IMMUNOGLOBULIN DEPOSITION IN DIABETIC GLOMERULI REQUIRES DIABETIC MODIFICATIONS TO BOTH GLOMERULI AND IMMUNOGLOBULIN
 Han Y, Nikolic-Paterson D, Kitching R, Tesch G
  179 TOLL LIKE RECEPTOR 9 ENHANCES GLOMERULAR INJURY IN ANCA VASCULITIS
 Summers S, Wongso H, Ford S, Gan P
  180 RESOLVINS INHIBIT INTERSTITIAL FIBROSIS IN THE OBSTRUCTED KIDNEY VIA INHIBITION OF LOCAL FIBROBLAST PROLIFERATION
 Li J, Qu X, Zhang X, Yao J, Song J, Nikolic-Paterson D
  181 ESTROGENS DO NOT PROTECT FROM AGEING NOR INJURY-RELATED KIDNEY FIBROSIS
 Hewitson T, Boon W, Simpson E, Samuel C
  182 OBESITY AND PODOCYTE DEPLETION IN CAUCASIAN AMERICAN MEN WITHOUT RENAL DISEASE
 Puelles V, Douglas-Denton R, Li J, Hughson M, Nyengaard J, Hoy W, Bertram J
  183 THE ROLE OF TOLL-LIKE RECEPTOR PROTEINS (TLR) 2 AND 4 IN MEDIATING INFLAMMATION IN HUMAN PROXIMAL TUBULAR CELLS (PTC)
 Mudaliar H, Chadban S, Wu H, Pollock C, Panchapakesan U
  184 HUMAN PROXIMAL TUBULE EPITHELIAL CELLS MODULATE AUTOLOGOUS DENDRITIC CELL FUNCTION
 Sampangi S, Kassianos A, Wang X, Healy H, Wilkinson R
  185 SIGNIFICANT PROTECTION BY EPCR OVEREXPRESSION IN MOUSE MODELS OF TRANSPLANTATION
 Lee E, Lu B, Roussel J, Murray-Segal L, Salvaris E, Hodgkinson S, Hall B, d’Apice A, Cowan P, Gock H
  186 PROTECTION BY CD39 ACTIVITY AND CD73 DEFICIENCY IN KIDNEY ISCHAEMIA REPERFUSION INJURY (IRI) IS DEPENDENT ON ADENOSINE 2B RECEPTOR SIGNALLING
 Rajakumar S, Lu B, Robson S, d’Apice A, Cowan P, Dwyer K
1900–2330 GALA DINNER

WEDNESDAY 29 AUGUST 2012

0830–1000TJ Neale Award 2011
  Prof Steven Chadban
 TJ Neale Award 2012
  Dr Greg Tesch
 Renal regeneration in zebrafish
  A/Prof Alan Davidson
  Chair: Prof Paolo Ferrari
1000–1100 PLENARY SESSION 3
 New insights into the role of complement in glomerulonephritis – C3 glomerulopathy
  Prof Terry Cook
  Imperial College London, UK
  Chair: A/Prof Kevan Polkinghorne
  Proudly sponsored by Sanofi, Pfizer and Roche
1100–1130 MORNING TEA AMONGST THE EXHIBITION
1130–1300 ORAL MINI-POSTERS 13
  Epidemiology & Public Health
  Co-Chairs: A/Prof Stephen McDonald, A/Prof Mark Marshall
  187 RELATIVE ENERGY BALANCE, CHRONIC KIDNEY DISEASE AND RISK OF CARDIOVASCULAR AND ALL-CAUSE MORTALITY
 Iff S, Wong G, Webster A, Flood V, Wang J, Mitchell P, Craig J
  188 URINARY BIOMARKERS MAY HELP PREDICT RENAL DECLINE IN PATIENTS WITH CHRONIC KIDNEY DISEASE
 Lee D, Cai M, Smith E, Ford M, Tomlinson L, Rajkumar C, McMahon L, Holt S
  189 IT IS A RISKY BUSINESS: NEW METRICS FOR ASSESSING CANDIDATE BIOMARKERS
 Pickering J, Endre Z
  190 ANGIOTENSIN CONVERTING ENZYME 2 IN CHRONIC KIDNEY DISEASE
 Roberts M, Velkoska E, Ierino F, Burrell L
  191 SERUM FETUIN-A AND BONE MINERAL MARKERS AMONG PATIENTS WITH CHRONIC KIDNEY DISEASE STAGE 3 AND 4
 Krishnasamy R, Elder G, Hawley C, Isbel N
  192 ASSOCIATIONS OF 25-OH VITAMIN D AND PARATHYROID HORMONE LEVELS IN SUBJECTS WITH MILD TO MODERATE CHRONIC KIDNEY DISEASE
 Damasiewicz M, Lu Z, Sikaris K, Kerr P, Polkinghorne K
  193 SCREENING FOR MAJOR CARDIOVASCULAR RISK FACTORS IN A DENSELY POPULATED UNDERPRIVILEGED OLD URBAN AREA OF BANGLADESH
 Hossain R, Iqbal M, Alam M, Ahmed A, Islam S, Chowdhury A, Rahman M
  194 COMPARATION COLD PRESSOR TEST BETWEEN STUDENT WITH AND WITHOUT GENETICALLY HYPERTENSION HISTORY IN SCHOOL OF MEDICINE SYIAH KUALA UNIVERSITY
 SYUKRI M, SIREGAR R, IRMAYANTI P
  195 OBESITY AS A RISK FACTOR FOR DECLINING KIDNEY FUNCTION: SIX YEARS COMMUNITY BASE COHORT
 Sutarka N, Widiana R, Suwitra K, Loekman J, Sudana W, Kandarini Y
  196 CKD.QLD SITE SURVEY 2: CHRONIC KIDNEY DISEASE AND CARDIOVASCULAR MONITORING IN QUEENSLAND
 Venuthurupalli S, Hoy W, Healy H, Salisbury A, Fassett R
  197 DATA MANAGEMENT LOGISTIC FRAMEWORK FOR THE REGISTRY OF CKD.QLD
 Wang Z, Salisbury A, Venuthurupalli S, Healy H, Fassett R, Hoy W
  198 CHRONIC KIDNEY DISEASE REGISTRY, QUEENSLAND (CKD.QLD REGISTRY) PROGRESS REPORT
 Venuthurupalli S, Hoy W, Healy H, Salisbury A, Fassett R
  199 CKD.QLD REGISTRY PROVIDES AN EPIDEMIOLOGICAL PLATFORM FOR ANSWERING FUTURE CLINICAL QUESTIONS
 Healy H, Wang Z, Mallett A, Huynh S, Coleman S, Kark A, Venuthurupalli S, Fassett R, Hoy W
1130–1300 ORAL MINI-POSTERS 14
  Chronic Kidney Disease 3
  Co-Chairs: A/Prof David Mudge, Dr Viliami Tutone
  200 THE CHARACTERISTICS OF UNINEPHRIC CHRONIC KIDNEY DISEASE PATIENTS
 Mallett A, Wang Z, Healy H, John G, Fassett R, Salisbury A, Hoy W
  201 CKD.QLD SURVEY OF DIALYSIS MODALITY PLANNING AND ACCESS CREATION IN CHRONIC KIDNEY DISEASE (CKD) PATIENTS IN QUEENSLAND
 Venuthurupalli S, Hoy W, Healy H, Salisbury A, Fassett R
  202 ETHNIC DIFFERENCES IN CREATININE KINETICS IN NEW ZEALANDERS
 Sun T, Kendrick-Jones J, Marshall M
  203 BIOLOGICAL VARIATION AND INTERPRETATION OF PLASMA FGF23 MEASUREMENT IN HEALTHY ADULTS AND IN CKD PATIENTS
 Smith E, Cai M, Tran D, McMahon L, Holt S
  204 THE ASSOCIATION BETWEEN SOCIAL SUPPORT AND PSYCHOSOCIAL FACTORS UPON MORTALITY AND QUALITY OF LIFE
 Bunani A, Sedgewick J, Lehbi A
  205 DOES INTENSIVE NUTRITIONAL INTERVENTION IN ADULTS WITH CHRONIC KIDNEY DISEASE (CKD) IMPROVE NUTRITIONAL STATUS AND QUALITY OF LIFE (QOL)?
 Sekula J, Wall C, Collins J, Lloyd L
  206 EFFECTS OF ELEVATED OSTEOPROTEGERIN ON DECLINE IN RENAL FUNCTION AND CLINICAL EVENTS IN ELDERLY WOMEN
 Lewis J, Lim W, Zhu K, Dhaliwal S, Lim E, Ueland T, Bollerslev J, Prince R
 207 ENHANCING SAFE ADMINISTRATION OF ANTICOAGULATION THERAPY IN SAUDI ARABIA – A CHALLENGE IN NURSING PRACTICE
 Bunani A, Sedgewick J, Lehbi A
  208 EFFECT OF RELIEF OF BILIARY OBSTRUCTION ON SERUM CREATININE
 Pan F, Spanger M, McMahon L, Smith E, Holt S
  209 CHRONIC KIDNEY DISEASE AND RISK OF DEATH FROM CANCER
 Iff S, Craig J, Kieu A, Wang J, Mitchell P, Wong G
1130–1300 ORAL MINI-POSTERS 15
  Transplantation 2
  Co-Chairs: Dr Ian Dittmer, Dr Carolyn Clark
  210 CLINICAL PRACTICE GUIDELINES ON WAITLISTING FOR KIDNEY TRANSPLANTATION: CONSISTENT AND EQUITABLE?
 Batabyal P, Chapman J, Wong G, Craig J, Tong A
  211 THE EXPERIENCES OF COMMERCIAL KIDNEY DONORS: THEMATIC SYNTHESIS OF QUALITATIVE RESEARCH
 Tong A, Chapman J, Wong G, Cross N, Batabyal P, Craig J
  212 PATIENT PREFERENCES FOR THE ALLOCATION OF DECEASED DONOR KIDNEYS FOR TRANSPLANTATION: A MIXED METHODS STUDY
 Tong A, Jan S, Wong G, Craig J, Irving M, Chadban S, Cass A, Marren N, Howard K
  213 EXERCISE TRAINING IN SOLID ORGAN TRANSPLANT RECIPIENTS – A SYSTEMATIC REVIEW
 Didsbury M, McGee R, Tong A, Craig J, Wong G
  214 RENAL ALLOGRAFT OUTCOMES IN POORLY MATCHED LIVE RENAL DONOR TRANSPLANTS WITH AND WITHOUT BASILIXIMAB INDUCTION
 Sakhuja V, Gundlapalli S, Kohli H, Jha V, Rathi M, Minz M
  215 IMPROVEMENT IN GFR WITH CNI-TO-EVEROLIMUS BASED REGIMENS IN ESTABLISHED RENAL TRANSPLANT RECIPIENTS WITH LOW IMMUNOLOGICAL RISK
 Cheng V, Mathew M, Gock H
  216 HEALTH RELATED QUALITY OF LIFE OF PATIENTS AWAITING KIDNEY AND SIMULTANEOUS PANCREAS KIDNEY TRANSPLANTATION
 M Myint T, O'Shaughnessy D, Marshall S, Vucak-Dzumhur M, Elder G
  217 SEROLOGIC PROFILES IN RENAL TRANSPLANT CANDIDATES IN JAKARTA
 Armelia L, Bonar M, Susalit E
  218 THE FREQUENCY AND QUALITY OF REPORTING OF QUALITY OF LIFE DATA IN TRIALS OF IMMUNOSUPPRESSIVE AGENTS IN KIDNEY TRANSPLANTATION
 Howell M, Wong G, Tong A, Turner R, Craig J, Howard K
  219 DOES CONTRAST ULTRASOUND (US) ADD TO THE ASSESSMENT OF RENAL TRANSPLANT FUNCTION IN THE EARLY POST-OPERATIVE PERIOD? A PILOT STUDY
 Graves A, Thomas M, Yong K, Warr K, Swaminathan S, Mendelson R, Elliott C, Zelesco M
  220 DOES EARLY PERFUSION OF RENAL TRANSPLANT AS ASSESSED BY CONTRAST ULTRASOUND (US) PREDICT 6 WEEK CLINICAL OUTCOME OF GRAFT? A PILOT STUDY
 Graves A, Thomas M, Yong K, Warr K, Swaminathan S, Mendelson R, Elliott C, Zelesco M
  221 THE EFFECT OF LAPROSCOPIC NEPHRECTOMY ON RENAL FUNCTION IN LIVING KIDNEY DONORS
 Eberhard J, Pidgeon G, Leikis M, Matheson P, MacDonald A, Hay N
  222 NEW-ONSET DIABETES AFTER TRANSPLANTATION (NODAT)
 Arnold L, Leikis M, Pidgeon G, Hay N, Macdonald A, Matheson P
  223 HEPATITIS C VIRUS (HCV) ERADICATION WITH PEGYLATED INTERFERON (PEG-IFN) AND REDUCED DOSE OF RIBAVIRIN (RVN) IN PRETRANSPLANT HAEMODIALYSIS (HD) PATIENTS: A SINGLE CENTRE EXPERIENCE
 Thet Z, Trevillian P, Jones T, Ianna L, Gibson R
  224 VASCULAR CALCIFICATION IN PATIENTS UNDERGOING KIDNEY AND SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANT ATION
 Chau K, Martinez G, Elder G
  225 25-OH VITAMIN D (25OHD) LEVELS AND SHORT TERM OUTCOMES IN INCIDENT RENAL TRANSPLANT RECIPIENTS (RTR)
 Damasiewicz M, Carroll R, Kerr P, Polkinghorne K, Mulley W
1130–1300 ORAL MINI-POSTERS 16
  Experimental Tubulointerstitial Disease 3
  Co-Chair: Dr Helen Healy, A/Prof Robyn Langham
  226 PASSAGE RELATED SENESCENCE OF PRIMARY HUMAN PROXIMAL TUBULE EPITHELIAL CELLS IS INDEPENDENT OF DONOR AGE
 Wang X, Wilkinson R, Healy H
  227 THE INHIBITION OF NOX4 AMELIORATED THE FIBROTIC RESPONSES IN VITRO AND IN DIABETIC MOUSE KIDNEYS
 Yong R, Saad S, Qi Y, Vijayaraj S, Huang C, Chen X, Pollock C
  228 OXIDATIVE STRESS-INDUCED ALTERATIONS IN MITOCHONDRIAL HOMEOSTASIS IN HUMAN PROXIMAL TUBULAR EPITHELIAL CELLS
 Small D, Bennett N, Coombes J, Johnson D, Gobe G
  229 MMP-9 PLAYS A ROLE IN ENDOTHELIAL-MESENCHYMAL TRANSITION BY NOTCH SIGNALING PATHWAY IN HUMAN RENAL GLOMERULAR ENDOTHELIAL CELLS
 Zhao Y, Tan T, Zhang J, Lee S, Zhao H, Wang C, Wang Y, Wang Y, Wang Y, Lee V, Tsatralis T, Alexander S, Zheng G, Harris D
  230 KCA3.1 MEDIATED THE ACTIVATION OF HUMAN RENAL FIBROBLASTS AND FIBROTIC RESPONSES IN VITRO AND IN DIABETIC MICE KIDNEYS
 Huang C, Chen X, Pollock C
  231 ISOMETRIC VACUOLATION IN THE PROXIMAL CONVOLUTED TUBULES OF AMP-ACTIVATED PROTEIN KINASE (AMPK) β1 NULL MICE
 Choy S, Fraser S, Katerelos M, Gleich K, Mount P, Kemp B, Power D
  232 UPREGULATION OF NUCLEAR FACTOR KAPPA B (NF-κB)/REL PROTEINS IN CYSTIC EPITHELIAL AND INTERSTITIAL CELLS IN HUMAN AND EXPERIMENTAL POLYCYSTIC KIDNEY DISEASE (PKD)
 Ta M, Schwensen K, Harris D, Rangan G
  233 MATRIX METALLOPROTEINASE-12 (MMP-12) PLAYS A PROTECTIVE ROLE IN THE RECOVERY FROM RENAL ISCHAEMIA-REPERFUSION INJURY
 Abraham A, Ma F, Mulley W, Ozols E, Nikolic-Paterson D
  234 THE ROLE OF SPHINGOSINE 1-PHOSPHATE IN THE DEVELOPMENT OF DIABETIC NEPHROPATHY
 Yaghobian D, Don A, Yaghobian S, Chen X, Saad S, Pollock C
  235 CONDITIONAL DEPLETION OF E-CADHERIN IN RENAL PROXIMAL TUBULAR CELLS PROMOTES EPITHELIAL-MESENCHYMAL TRANSITION AND KIDNEY FIBROSIS THROUGH UPREGULATION OF α3 INTEGRIN
 Zheng G, Lee S, Zhang J, Zhao H, Hsu T, Tan T, Zhao Y, Loebel D, Wang Y, Wang Y, Cao Q, Wang C, Lee V, T P, Harris D
  236 THERAPEUTIC POTENTIAL OF PERITONEAL MONONUCLEAR PHAGOCYTES
 Wang C, Cao Q, Yu X, Wang Y, Harris D
1300–1400 LUNCH AMONGST THE EXHIBITION
1400 ASM CONCLUDES

Ancillary